References
Alvarez Moreno C. Las enfermedades infecciosas emergentes. In: Editorial médica panamericana, editor. Salud Pública Conceptos, aplicaciones y desafíos. 3ra ed. 2019. p. 848.
Centers for Disease Control and Prevention. Lesson 6: Investigating an Outbreak [Internet]. Principles of Epidemiology in Public Health Practice, Third Edition. An Introduction to Applied Epidemiology and Biostatistics. 2012 [cited 2020 Feb 3]. Available from: https://www.cdc.gov/csels/dsepd/ss1978/lesson6/section1.html
Fan Y, Zhao K, Shi ZL, Zhou P. Bat coronaviruses in China. Viruses. 2019;11(3):27-32. https://doi.org/10.3390/v11030210
Nuclear Threat Initiative (NTI); Johns Hopkins Center for Health Security (JHU); The Economist Intelligence Unit (EIU). 2019 Global Health Security Index [Internet]. [cited 2020 Feb 29]. Available from: https://www.ghsindex.org/
Schoeman D, Fielding BC. Coronavirus envelope protein: Current knowledge. Virol J. 2019;16(1):1-22. https://doi.org/10.1186/s12985-019-1182-0
WHO. The First Few X ( FFX ) Cases and contact investigation protocol for 2019-novel coronavirus ( 2019-nCoV ) infection. 2020.
Otter JA, Donskey C, Yezli S, Douthwaite S, Goldenberg SD, Weber DJ. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect. 2016 Mar;92(3):235-50. https://doi.org/10.1016/j.jhin.2015.08.027
WHO. Novel Coronavirus ( 2019-nCoV )-Situation report-10. 2020. https://doi.org/10.13070/mm.en.10.2867
WHO. Novel Coronavirus ( 2019-nCoV ) Situation report-20. 2020.
Wang FS, Zhang C. What to do next to control the 2019-nCoV epidemic? Lancet. 2020;395(10222):391-3. https://doi.org/10.1016/S0140-6736(20)30300-7
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;(January):2019-21. https://doi.org/10.1038/s41422-020-0282-0